Pulmonary vascular resistance and compliance in individuals with trisomy 18.
chromosomal anomaly
congenital heart disease
pulmonary circulation
pulmonary hypertension
trisomy 21
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
14
08
2021
received:
12
05
2021
accepted:
16
10
2021
pubmed:
4
11
2021
medline:
8
4
2022
entrez:
3
11
2021
Statut:
ppublish
Résumé
Individuals with trisomy 18 (T18) usually have congenital heart disease, often with pulmonary hypertension, which is associated with poor outcomes. This study aimed to explore the characteristics of pulmonary circulation including pulmonary vascular resistance (Rp) and compliance (Cp) among them. We retrospectively reviewed cardiac catheterization data in subjects with T18, trisomy 21 (T21), and without chromosomal anomaly (control group) who were referred due to heart failure associated with ventricular septal defect between 2000 and 2020. Pulmonary hemodynamic parameters including Rp and Cp were compared between these groups. We studied 20 subjects with T18, 88 subjects with T21, and 240 control subjects. There was no significant difference in age (T18: 4.6 [3.0-6. 9] vs. T21: 2.8 [1.9-4.0] vs. control: 2.9 [1.6-3.2] months, p = 0.06) and mean pulmonary arterial pressure (T18: 41 [33-49] vs. T21: 35 [30-41] vs. control: 36 [28-43] mmHg, p = 0.121) between the groups. The pulmonary to systemic blood flow ratio (Qp/Qs) (p = 0.983), Rp (p = 0.449), and Cp (p = 0.195) did not differ between T18 and control groups. However, Qp/Qs and Cp in T18 group were significantly greater than that in T21 group (T18: Qp/Qs: 3.4 [2.3-5.2] vs. T: 21 2.3 [1.7-3.7], p = 0.001. Cp: 3.5 [2.3-5.5] vs. 2.3 [1.6-3.1] mmHg/mL/m
Identifiants
pubmed: 34729911
doi: 10.1002/ajmg.a.62550
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
534-539Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Cereda, A., & Carey, J. C. (2012). The trisomy 18 syndrome. Orphanet Journal of Rare Diseases, 7, 81. https://doi.org/10.1186/1750-1172-7-81
Doi, H., Muneuchi, J., Watanabe, M., Sugitani, Y., Matsuoka, R., Ezaki, H., & Ochiai, Y. (2021). Characteristics of the pulmonary circulation in infants with complete atrioventricular septal defect. Cardiology in the Young, 31(4), 556-561. https://doi.org/10.1017/S1047951120004424
Furukawa, T., Sunamura, M., & Horii, A. (2006). Molecular mechanisms of pancreatic carcinogenesis. Cancer Science, 97(1), 1-7. https://doi.org/10.1111/j.1349-7006.2005.00134.x
Galambos, C., Minic, A. D., Bush, D., Nguyen, D., Dodson, B., Seedorf, G., & Abman, S. H. (2016). Increased lung expression of anti-angiogenic factors in down syndrome: Potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS One, 11(8), e0159005. https://doi.org/10.1371/journal.pone.0159005
Ghio, S., Schirinzi, S., & Pica, S. (2015). Pulmonary arterial compliance: How and why should we measure it? Global Cardiology Science and Practice, 2015(4), 58. https://doi.org/10.5339/gcsp.2015.58
Hawkins, A., Langton-Hewer, S., Henderson, J., & Tulloh, R. M. (2011). Management of pulmonary hypertension in down syndrome. European Journal of Pediatrics, 170(7), 915-921. https://doi.org/10.1007/s00431-010-1378-1
Iida, C., Muneuchi, J., Yamamoto, J., Yokota, C., Ohmura, J., Kamimura, T., Ochiai, Y., Matsumoto, N., Araki, S., Shimizu, D., Yamaguchi, K., Sakemi, Y., Watanabe, M., Sugitani, Y., Takahashi, Y., & Kitakyushu Neonatal Research Group. (2020). Impacts of surgical interventions on the long-term outcomes in individuals with trisomy 18. Journal of Pediatric Surgery, 55(11), 2466-2470. https://doi.org/10.1016/j.jpedsurg.2019.12.009
Iwaya, Y., Muneuchi, J., Inoue, Y., Watanabe, M., Okada, S., & Ochiai, Y. (2019). Relationship between pulmonary arterial resistance and compliance in patients with Down syndrome. Pediatric Cardiology, 40(4), 841-847. https://doi.org/10.1007/s00246-019-02080-9
Iwaya, Y., Muneuchi, J., Watanabe, M., Sugitani, Y., & Ochiai, Y. (2020). Decreased pulmonary arterial compliance is a predictor for poor outcomes in infants with isolated atrial septal defect and pulmonary hypertension. Pediatric Cardiology, 41(7), 1408-1413. https://doi.org/10.1007/s00246-020-02400-4
Ma, L., & Chung, W. K. (2014). The genetic basis of pulmonary arterial hypertension. Human Genetics, 133(5), 471-479. https://doi.org/10.1007/s00439-014-1419-3
Muneuchi, J., Nagatomo, Y., Watanabe, M., Joo, K., Onzuka, T., Ochiai, Y., & Joo, K. (2016). Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease. The Journal of Thoracic and Cardiovascular Surgery, 152(2), 507-513. https://doi.org/10.1016/j.jtcvs.2016.03.080
Nelson, K. E., Rosella, L. C., Mahant, S., & Guttmann, A. (2016). Survival and surgical interventions for children with trisomy 13 and 18. JAMA, 316(4), 420-428. https://doi.org/10.1001/jama.2016.9819
Pellegrini, P., Rossi, A., Pasotti, M., Raineri, C., Cicoira, M., Bonapace, S., Dini, F. L., Temporelli, P. L., Vassanelli, C., Vanderpool, R., Naeije, R., & Ghio, S. (2014). Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest, 145(5), 1064-1070. https://doi.org/10.1378/chest.13-1510
Rasmussen, S. A., Wong, L. Y., Yang, Q., May, K. M., & Friedman, J. M. (2003). Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics, 111(4 Pt 1), 777-784. https://doi.org/10.1542/peds.111.4.777
Saji, T. (2014). Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatrics International, 56(3), 297-303. https://doi.org/10.1111/ped.12349
Shott, S. R., Amin, R., Chini, B., Heubi, C., Hotze, S., & Akers, R. (2006). Obstructive sleep apnea: Should all children with Down syndrome be tested? Archives of Otolaryngology - Head & Neck Surgery, 132(4), 432-436. https://doi.org/10.1001/archotol.132.4.432
Tahara, M., Sanada, K., Morita, R., Hawaka, H., Urayama, K., Sugino, M., Masaki, N., & Yamaki, S. (2021). Insufficient development of vessels and alveoli in lungs of infants with trisomy 18-features of pulmonary histopathological findings from lung biopsy. American Journal of Medical Genetics. Part A, 185(4), 1059-1066. https://doi.org/10.1002/ajmg.a.62060
Tahara, M., Shimozono, S., Nitta, T., & Yamaki, S. (2014). Medial defects of the small pulmonary arteries in fatal pulmonary hypertension in infants with trisomy 13 and trisomy 18. American Journal of Medical Genetics. Part A, 164A(2), 319-323. https://doi.org/10.1002/ajmg.a.36282
Takatsuki, S., Nakayama, T., Ikehara, S., Matsuura, H., Ivy, D. D., & Saji, T. (2017). Pulmonary arterial capacitance index is a strong predictor for adverse outcome in children with idiopathic and heritable pulmonary arterial hypertension. The Journal of Pediatrics, 180, 75-79.e2. https://doi.org/10.1016/j.jpeds.2016.10.003
Yamaki, S. (2013). Pulmonary vascular disease associated with pulmonary hypertension in 445 patients: Diagnosis from lung biopsy and autopsy. General Thoracic and Cardiovascular Surgery, 61(1), 24-31. https://doi.org/10.1007/s11748-012-0155-7